Heart Disease Trial, Recruiting NCT07354568 Sponsor: Centre Hospitalier Universitaire, Amiens Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT07354568
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are over 18 years of age
  • People who have been admitted to an intensive care unit for a serious heart-related condition where the heart is not pumping enough blood (cardiogenic shock), at a severity level meeting a specific medical threshold (at least SCAI stage C — confirm with trial site)
  • People who have not objected to their data being used for the study

Who may not be able to join:

  • People whose medical records are missing important information, particularly details about medications used to support blood pressure and about what happened during their care
  • People who are pregnant
  • People whose shock is caused by certain other conditions, including severe allergic reactions, bleeding alone, serious burns or major physical trauma, severe inflammation of the pancreas, sudden liver failure, or a nervous system-related cause
  • People who are adults currently under a legal protection arrangement, such as guardianship, curatorship, or court-ordered protection

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: + 33 322087866

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier Universitaire, Amiens
Registry
ClinicalTrials.gov
Start date
20 October 2025
Est. completion
1 January 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

All-cause mortality at 90 days

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov